{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-134570","form_type":"8-K","ticker":"STE","cik":"0001757898","company_name":"STERIS plc","filed_at":"2023-05-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.409241+00:00","generated_at":"2026-06-16T01:23:39.507473+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"STERIS appoints Esther Alegria to Board of Directors effective May 3, 2023","bullets":["Board size increased to ten members; Dr. Alegria, age 64, appointed immediately.","She is Founder & CEO of APIE Therapeutics; previously SVP Global Manufacturing at Biogen.","Prorated director fee of $74,220 payable in restricted stock units for remainder of 2022-23 term.","Also serves on AVID Bioservices (NASDAQ: CDMO) board and its audit and governance committees."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-134570","json":"https://secwatch.observer/filing/0001193125-23-134570.json","markdown":"https://secwatch.observer/filing/0001193125-23-134570.md","text":"https://secwatch.observer/filing/0001193125-23-134570.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1757898/000119312523134570/0001193125-23-134570-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1757898/000119312523134570/d287600d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T01:23:39.507473+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c692da444c","claim":"Esther Alegria was elected as Director at STERIS plc.","evidence_excerpt":"The Board of Directors (the “Board”) of STERIS plc (the “Company”) increased its size from nine to ten members on May 3, 2023, and elected Dr. Esther Alegria to serve as a director effective as of that date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1757898/000119312523134570/0001193125-23-134570-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}